Search - tctmd.com

Displaying 161 - 180 of 269

Sort: Relevancy | Date

Presentation TCT 2017

Case #3: Transapical Mitral ViV With Lotus (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Vinayak Bapat

October 30, 2017

Presentation TCT 2017

Case #2: TAVR ViV With SAPIEN 3 (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Anupama Shivaraju

October 30, 2017

Presentation TCT 2017

Case #1: Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Implantation: Concept to First-in-Human BASILICA Procedures (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Danny Dvir

October 30, 2017

Presentation TCT 2017

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

Presenter: John S. Douglas Jr, Valerian Fernandes, Vivek Y. Reddy

October 30, 2017

News Industry News TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

November 02, 2016

Presentation TCT 2016

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the WaveCrest LAA Occluder

Presenter: Krzysztof Bartus, Vivek Y. Reddy

November 01, 2016

Presentation TCT 2016

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Presenter: Zahid Amin, Jacqueline Saw, Vivek Y. Reddy

October 31, 2016

Presentation TCT 2016

Editorial perspective: Interventional Treatment of Atrial Fibrillation: Current Strategy and Unmet Needs

Presenter: Vivek Y. Reddy

October 31, 2016

Presentation TCT 2016

TransMitral Valve Replacement (VIV) Within a St. Jude Mechanical Mitral Valve

Presenter: Danny Dvir, Marco Moscarelli, J. Bradley Oldemeyer

October 31, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

Rationale for and Outcomes of LAA Closure Plus Pulmonary Vein Isolation

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Jamil Abdalla Saad

October 30, 2016

Presentation TCT 2016

Early Clinical Results With the Cardia LAA Occluder (and Future Studies)

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Josep Rodés-Cabau

October 30, 2016

Presentation TCT 2016

Early and Late Results With the LAmbre LAA Occluder (and Future Studies)

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Yat-Yin Lam

October 30, 2016

Presentation TCT 2016

Early and Late Results With the Wavecrest LAA Occluder (and Future Studies)

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Gregg W. Stone

October 30, 2016

Presentation TCT 2016

Early and Late Results With the Occlutech LAA Occluder (and Future studies)

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Horst Sievert

October 30, 2016

Presentation TCT 2016

Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients: Certainties, Data Gaps, and Future Studies

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Apostolos Tzikas

October 30, 2016

Presentation TCT 2016

Bioprosthetic Valve Failure: TAVR Clinical and Hemodynamic Results From the VIVID Registry and Other Studies

Presenter: A. Pieter Kappetein, Allan Schwartz, Danny Dvir

October 30, 2016

Presentation TCT 2016

Real-world Watchman Outcomes: Insights From the EWOLUTION European Registry

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Martin W. Bergmann

October 30, 2016

Presentation TCT 2016

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr.

October 30, 2016

Advertisement

Case #3: Transapical Mitral ViV With Lotus (With Discussion)

Case #2: TAVR ViV With SAPIEN 3 (With Discussion)

Case #1: Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Implantation: Concept to First-in-Human BASILICA Procedures (With Discussion)

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Special Tips and Tricks for LAA Closure Using the WaveCrest LAA Occluder

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Editorial perspective: Interventional Treatment of Atrial Fibrillation: Current Strategy and Unmet Needs

TransMitral Valve Replacement (VIV) Within a St. Jude Mechanical Mitral Valve

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Rationale for and Outcomes of LAA Closure Plus Pulmonary Vein Isolation

Early Clinical Results With the Cardia LAA Occluder (and Future Studies)

Early and Late Results With the LAmbre LAA Occluder (and Future Studies)

Early and Late Results With the Wavecrest LAA Occluder (and Future Studies)

Early and Late Results With the Occlutech LAA Occluder (and Future studies)

Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients: Certainties, Data Gaps, and Future Studies

Bioprosthetic Valve Failure: TAVR Clinical and Hemodynamic Results From the VIVID Registry and Other Studies

Real-world Watchman Outcomes: Insights From the EWOLUTION European Registry

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content